To understand the underlying molecular mechanism by which vinculin suppresses CRC invasion and metastasis, we further investigated whether β-catenin, an important binding partner of vinculin and a key activator of cancer malignant phenotypes, was involved in this process. Here, VCL is linked to colorectal carcinoma.